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Huntington’s disease (HD), a devastating neurode-
generative disorder, strongly affects the corticostria-
tal network, but the contribution of pre- and postsyn-
aptic neurons in the first phases of disease is unclear
due to difficulties performing early subcellular inves-
tigations in vivo. Here, we have developed an on-
a-chip approach to reconstitute an HD corticostriatal
network in vitro, using microfluidic devices compat-
ible with subcellular resolution. We observed major
defects in the different compartments of the cortico-
striatal circuit, from presynaptic dynamics to synap-
tic structure and transmission and to postsynaptic
traffic and signaling, that correlate with altered global
synchrony of the network. Importantly, the genetic
status of the presynaptic compartment was neces-
sary and sufficient to alter or restore the circuit.
This highlights an important weight for the presynap-
tic compartment in HD that has to be considered for
future therapies. This disease-on-a-chip microfluidic
platform is thus a physiologically relevant in vitro sys-
tem for investigating pathogenic mechanisms and
for identifying drugs.
INTRODUCTION
Huntington’s disease is a devastating inherited neurological dis-
order with late-onset manifestations including involuntary move-
ments and psychiatric and cognitive symptoms. Neuropathology
includes the selective dysfunction and neurodegeneration of
medium spiny neurons from the striatum and of specific cortical
neurons within the cerebral cortex. Several pathogenic mecha-
nisms potentially contributing to Huntington’s disease (HD)
have been described (Ross and Tabrizi, 2011; Saudou and Hum-
bert, 2016). In particular, early defects in the corticostriatal cir-
cuitry with alteration of pre- and/or postsynaptic compartments110 Cell Reports 22, 110–122, January 2, 2018 ª 2017 The Author(s)
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Zuccato et al., 2010). In support, the development of several an-
imal models that recapitulate the clinical features of HD led to the
observation of synaptic alterations, revealing potential defects in
neuronal connectivity (Cepeda et al., 2003; Gatto et al., 2015).
Also, fMRI in presymptomatic patients revealed early alteration
of cortex and striatum as well as defects in connectivity (Rosas
et al., 2010; Tabrizi et al., 2011). Although it is now clear that
both cortical and striatal neurons participate in the pathogenic
process, their exact contributions to the early process of
neuronal dysfunction is debated.
Elegant in vivo studies aiming at reducing the expression of
transgenicmutant polyQ-HTT in either cortical or striatal neurons
of mice that express full-length human mutant HTT from a bac-
terial artificial chromosome transgene (BACHD) suggested that
both compartments were contributing to late degeneration
(Wang et al., 2014). However, the cortical and striatal promoters
used in this study only partially reduced mutant polyQ-HTT
expression, and the cortical promoter was not selective since it
also reduced striatal expression. To circumvent the difficulties
of such in vivo experiments and study early dysfunction
processes, strategies using co-culturing of cortical and striatal
cultures in dishes have been reported (Buren et al., 2016). These
primary neurons resemble the in vivo environment more closely
than cell lines, but their random distribution in culture may lead
to the creation of nonspecific, multidirectional, uncontrolled con-
nections between the two populations, making it difficult to inter-
pret the mechanisms involved in the disease. There is, therefore,
a crucial need to developmore physiological and controlled con-
texts for reproducing the corticostriatal connections found in vivo
while keeping subcellular resolution for studying the early mech-
anisms underlying neuronal dysfunction.
Here we present a microfluidic platform for the in vitro recon-
struction of healthy and HD networks in which each neuronal
compartment (presynaptic, synaptic, and postsynaptic) is iden-
tified (space compartmentalization) and in which the progression
from axonal growth to synapse regulation is controlled (time
compartmentalization). This microfluidic device is compatible
with high-resolution videomicroscopy for studying intracellular.
creativecommons.org/licenses/by-nc-nd/4.0/).
dynamics selectively in each compartment as well as global
circuit functioning. We built a fluidically isolated corticostriatal
network using neurons from an HD mouse model to investigate
alterations in presynaptic dynamics, synaptic morphology and
transmission, postsynaptic trafficking and signaling, as well as
their consequences on global network dynamics in the patholog-
ical context of HD. Surprisingly, we found that presynaptic dys-
functions are necessary and sufficient to generate various
pathological features within the striatal compartment, suggest-
ing that cortical defects may be critical to the progression of
the disease. Conversely, wild-type cortical neurons are sufficient
to restore cellular alterations in mutant striatal neurons, suggest-
ing that the manipulation of cortical neurons may be sufficient to
achieve therapeutic effects. This disease-on-a-chip platform
may, therefore, be useful not only for investigating pathogenic
mechanisms but also for testing drugs of interest for HD treat-
ment. The versatility of the device makes it suitable for use in
other neurological disorders characterized by network or syn-
apse dysfunction.
RESULTS
Space and Time Compartmentalization of Healthy and
HD Corticostriatal Networks In Vitro
We reconstructed an in vitro corticostriatal network for subcellu-
lar investigations using the previous generation of polydimethyl-
siloxane (PDMS) microfluidic devices, which allow the access
and manipulation of synapses and their pre- and postsynaptic
compartments independently (Taylor et al., 2010). We modified
the device to optimize fluidic isolation and to reduce the number
of axons and dendrites to a unique branch in each channel by
reducing their width to 3 mm (Figure S1A). The device consisted
of two neuronal chambers (each containing either cortical or
striatal neurons) connected via an intermediate synaptic cham-
ber (containing corticostriatal synapses) through microchannels
of different lengths (500 mm for cortical neurons and 75 mm for
striatal neurons) (Figures 1A and S1A). The dendrites cannot
grow to lengths of more than 450 mm (Taylor et al., 2005), so
only axons from cortical neurons can reach the synaptic
compartment (Figure 1B). By contrast, the 75-mm-long micro-
channels emerging from the striatal compartment do not
discriminate between axons and dendrites, making it possible
for striatal dendrites to come into contact with cortical axons.
We limited the number of striatal axons reaching the synaptic
chamber, by generating a gradient of laminin from the cortical
chamber to the striatal chamber, while keeping the poly-D-lysine
concentration constant. This gradient helped to keep striatal
axons away from the synaptic compartment, thus preventing
non-physiological striatocortical contacts. In an effort to mimic
physiological corticostriatal projections, we enriched the cortical
chamber with CTIP2-/TBR1-positive neurons by performing pri-
mary cultures at embryonic day (E)15.5 (Digilio et al., 2015) (Fig-
ure S1B). These neurons corresponded to the deepest layers of
the cortex (i.e., layers V and VI) that send axons to subcortical
targets such as the striatum. Axons from cortical neurons
crossed the channels by 3 days in vitro (DIV 3), and they began
making contacts with striatal dendrites in the synaptic chamber
at around DIV 5. The synaptic chamber, which was devoid ofneuronal cells (Figure S1C), was progressively enriched in
mature corticostriatal synaptic contacts until DIV 14, as shown
by the juxtaposition of the presynaptic marker synaptophysin
and the postsynaptic marker PSD95 that reached a density of
108.2 ± 9.2 contacts/100 mm (n = 27 fields) (Figures 1C and
S1D). Glial Fibrillary Acidic Protein (GFAP)-positive branches
were also found around neurites and synaptic contacts in the
synaptic chamber, consistent with the formation of tripartite syn-
apses among axons, dendrites, and glial cells (Figure 1D).
Because cortical neurons were mostly glutamatergic, we
determined the functionality of corticostriatal synapsesby lentivi-
ral expression of the glutamate sensor iGluSnFR in the striatal
chamber (Marvin et al., 2013). We found that the synaptic con-
tacts were fully mature by DIV 14, as shown by the number
of fluorescent spots that reached a plateau at 109,300 ±
6,726/mm2 (n = 25 fields) in the synaptic chamber after stimula-
tion of cortical neurons with glycine/strychnine treatments (Fig-
ure 1E). To study corticostriatal network connectivity,we infected
striatal neurons with GCaMP6f, a fast genetically encoded cal-
cium sensor that reliably detects single action potentials (Chen
et al., 2013), and we recorded spontaneous neuronal activity.
We found that around 83% of striatal cells elicited spontaneous
and synchronized episodes of bursting activity at DIV 14 (Fig-
ure 1F). At DIV 14, the number of GCaMP6f events was 6.3 ±
0.1/cell/30 s, and 47.5% ± 14.6% of them were highly synchro-
nized (n = 751 cells) and remained constant (Movie S1), consis-
tent with matured neuronal cultures (Chiappalone et al., 2006).
Theseobservations demonstrate theefficacyof this device for re-
producing a physiological corticostriatal network in vitro in which
cortical neurons progressively form unilateral synapses with
striatal neurons via oriented axodendritic contacts surrounded
by astrocytes.
To study cellular and global dysfunctions in the diseased
network, we used cortical and striatal neurons from heterozy-
gous mice carrying a 140 CAG repeat in the mouse Htt gene
(Menalled et al., 2002) (HdhCAG140/+, referred to here as HD
mice). We did not notice major differences in the establishment
of wild-type and HD networks in the device. We then studied
multiple cellular alterations using a palette of selective markers
in each compartment to evaluate presynaptic dynamics, synap-
tic morphology and transmission, postsynaptic responses, as
well as the global consequences on network activity.
Axonal Transport of Vesicles Is Reduced in the Mature
HD Network
To study presynaptic alterations in corticostriatal projecting neu-
rons, we analyzed axonal transport of Brain-DerivedNeurotrophic
Factor (BDNF)-containing dense-core vesicles (DCVs) because it
is critically impaired in HD (Gauthier et al., 2004). We investigated
the transport of BDNF in cortical axons at the following different
stages of neuronal maturation: early (DIV 4, before synaptic con-
tacts), intermediate (DIV 10, immature synaptic contacts), and
late (DIV 18, mature synaptic contacts), using neurons from the
HD mouse model (Menalled et al., 2002). To do so, cortical neu-
rons were infected with a lentivirus expressing mCherry-tagged
BDNF (BDNF-mCh) at DIV 1 (Hinckelmann et al., 2016).
Fast video acquisitions were performed in the bottom part of
axonal microchannels to select for axonal transport withoutCell Reports 22, 110–122, January 2, 2018 111
Figure 1. In Vitro Reconstruction of Corticostriatal Network Using Microfluidics
(A) Schematic of the 3-compartment microfluidic device allowing fluidic isolation of cortical and striatal chambers that are connected via microchannels and an
intermediate synaptic chamber. Cylinders represent accessible wells for seeding neurons and/or perfusing liquids (culture medium or drugs). Microchannels are
different in length to allow axons from cortical neurons and dendrites from striatal neurons to reach the synaptic chamber. Inset shows silicon microfluidics fixed
to a microscopy-compatible glass-bottom microdish.
(B) Cortical axons connect striatal dendrites in the synaptic chamber. Axons (Tau positive), but not dendrites (MAP2 positive), from cortical neurons cross the
500-mm-long axonal channels to reach the synaptic and striatal chambers. Conversely, dendrites from striatal neurons reach the synaptic chamber by crossing
the 75-mm-long dendritic channels, while axons are preferentially kept away using a gradient of coating. Scale bar, 100 mm.
(C) Adjacent spots of synaptophysin (SYN, presynaptic marker) and PSD95 (postsynaptic marker) show the formation of synaptic contacts between cortical
axons and striatal dendrites in the synaptic chamber. Scale bar, 10 mm (inset, 200 nm).
(D) Striatal astrocytes (GFAP) grow extensions into the synaptic chamber that surround contacts between cortical axons (Cx-GFP) and striatal dendrites (MAP2).
Scale bar, 50 mm.
(E) Efficient glutamate release (iGluSnFR) from projecting cortical axons confirms functional corticostriatal connections in the synaptic chamber at DIV 14. White
arrows show glutamate release sites. Scale bar, 20 mm.
(F) Calcium imaging (GCaMP6f) shows high, synchronized neuronal activity in striatal neurons at DIV 14.White arrows indicate active neurons. Scale bar, 100 mm.
See also Figure S1 and Movie S1.dendritic contamination. Acquisitions were performed longitudi-
nally using the same microfluidics at DIV 4, 10, and 18 (Figures
2A–2C and S2A; Movie S2). Segmental velocities and the num-
ber of vesicles were reduced in both anterograde and retrograde
directions in HD neurons, suggesting that, in addition to a defect
in axonal transport per se, vesicle synthesis was also altered
in HD. This finding is consistent with previous reports of defects
in trafficking from the endoplasmic reticulum to the Golgi appa-
ratus and the plasma membrane in neurons from HD mouse
models (Borrell-Pagès et al., 2006; Gauthier et al., 2004). The
shift in the distribution of velocities and number of vesicles (Fig-
ure 2C) had a striking effect on the global linear flow rate of112 Cell Reports 22, 110–122, January 2, 2018vesicle trafficking in axons and on the net flux, with half as
much anterograde transport. These defects were already pre-
sent at the early stage, as previously reported in other studies
on immature free cultures (Gauthier et al., 2004; Her and Gold-
stein, 2008), but they became increasingly marked as the system
matured.
Mitochondrial Fragmentation and Motility Increase in
Mature Presynaptic HD Axons
Studies on the dynamics of mitochondria in the context of HD
have yielded conflicting results (Gauthier et al., 2004; Trushina
et al., 2004). We therefore investigated the axonal dynamics of
Figure 2. Progressive Dysfunctions of Presynaptic Dynamics in the HD Network
(A–C) Impaired axonal trafficking of DCVs (BDNF-mCh) from early to late neuronal maturation in HD.
(A) Kinetics analyses show altered axonal transport of motile vesicles inHdhCAG140/+ (HD) neurons compared to wild-type (WT) neurons at every stage of network
maturation: decreased velocities (anterograde, F1,490 = 96.3, ***p < 0.0001; retrograde, F1,490 = 24.4, ***p < 0.0001; n = 82), number (anterograde, F1,490 = 115.5,
***p < 0.0001; retrograde, F1,490 = 93.2, ***p < 0.0001), net flux (F1,490 = 215.8, ***p < 0.0001), and linear flow rate (F1,490 = 76.6, ***p < 0.0001).
(B) Representative kymographs show DCV axonal trafficking obtained in WT and HD neurons at DIV 14.
(C) Changes in the distribution of motile vesicles in axons in HD neurons are compared to WT neurons at DIV 14 (anterograde, X2 = 86.7, p < 0.0001; retrograde,
X2 = 28.5, p < 0.0001).
(D–G) Late alterations in mitochondria dynamics and fission (Mito-DsRed) in HD.
(D) Kinetics analyses show no defect in velocity at any stage of network maturation but show alterations at the latest stage: increased motility (late versus early:
anterograde, *p < 0.05; retrograde, *p < 0.05; n = 70) and decreased proportion of stationary mitochondria (***p < 0.001) leading to increased linear flow rate
(**p < 0.01), and in HD.
(E) Representative kymographs show mitochondria axonal trafficking obtained in WT and HD neurons at DIV 14.
(F) Increased number of small motile mitochondria in HD at DIV 14 (**p < 0.01; n = 32) indicates increased fission and motility at the latest stage of network
maturation.
(G) Decreased TMRM signal in HD neurons, which indicates functional defects in mitochondria (**p < 0.01 and ***p < 0.001; n = 120), is more pronounced in small
mitochondria (*p < 0.05). Error bar indicates SEM.
See also Figure S2 and Movies S2 and S3.
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mitochondria in our reconstituted HD network (Figures 2D–2F
and S2B; Movie S3). We found that the velocity of mitochondria
was unaffected regardless of the stage of network maturation.
By contrast, in the final stage of network maturation, we
observed an increase in the number of motile mitochondria, re-
sulting in a significant increase in the linear flow rate and a
decrease in the proportion of stationary episodes. We then
investigated the cause of this increase in the number of motile
mitochondria in the mature network. We found that a large pro-
portion of the motile mitochondria in the HD network were small,
whereas the number of elongated mitochondria did not differ be-
tween wild-type and mutant neurons (Figures 2F and S2C). The
increase in the number of small mitochondria, which are more
mobile, in the context of HD, is consistent with the increase in
mitochondrial fragmentation reported in vitro and in vivo (Costa
et al., 2010; Song et al., 2011). We also measured mitochondrial
membrane potential using tetramethylrhodamine, methyl ester
(TMRM) labeling in wild-type (WT) and HD neurons to assess
their functional integrity (Scaduto and Grotyohann, 1999). We
found that both small and large mitochondria were functionally
defective, as shown by the decrease in TMRM labeling (Fig-
ure 2G). Interestingly, the decrease in membrane potential was
significantly more pronounced in small mitochondria compared
to large ones. We conclude that, in contrast to the early defect
in axonal transport of BDNF, alteration in mitochondria traf-
ficking and function appears as a late event in the HD network.
The Corticostriatal Network Is Misconnected and
Dysfunctional in HD
Wenext investigated possible changes in the structure and func-
tion of corticostriatal synapses in themature HD circuit (>DIV 14).
We assessed synapse density by quantifying the number of syn-
aptophysin spots (presynaptic marker) adjacent to PSD95 spots
(postsynaptic marker) in the synaptic chamber using high-reso-
lution Airyscan confocal microscopy (Figures 3A and 3B). We
found that the frequency of synaptophysin being located next
to PSD95 was significantly lower in the HD corticostriatal
network than in the WT network. The overall number of synaptic
contacts was decreased in the HD network. The morphology of
remaining contacts was changed, with a higher proportion of
large and clustered presynaptic sites than in WT neurons (Fig-
ures 3C and 3D). We analyzed whether findings obtained in
microfluidics could be observed in brain corticostriatal slices
from HD mice. Using PSD95 as a postsynaptic marker and
VGLUT1 as a selective presynaptic marker for cortical projec-
tions (McKinstry et al., 2014), we confirmed that the number of
corticostriatal contacts was also decreased in vivo in the stria-
tum of HD mice (Figure S3). These in vivo observations therefore
validate our microfluidic platform as a predictive tool for detect-
ing alterations in the corticostriatal pathway.
We next investigatedwhether the altered synapticmorphology
affected the capacity of cortical neurons to release glutamate by
infecting striatal neurons with iGluSnFR-expressing lentiviruses
and performing live fluorescence acquisition on the synaptic
chamber during the stimulation of cortical neurons with glycine/
strychnine treatment (Figures 3E and 3F). We observed a signifi-
cant decrease in the density of glutamate presynaptic release
sites, as shown by the smaller number of iGluSnFR spots in the114 Cell Reports 22, 110–122, January 2, 2018synaptic chamber. The remaining iGluSnFR-positive spots
were significantly larger than those in WT conditions (Figure 3G),
consistent with the larger size of the presynaptic clusters de-
tected by immunostaining for synaptophysin. Abnormally large
clusters of iGluSnFR and synaptophysin spots in presynaptic ter-
minals suggest aberrant synaptic release of excitatory neuro-
transmitter, which would be in agreement with the observed
increased excitatory release in HD flies (Romero et al., 2008).
HD Induces Defects in Postsynaptic Trafficking and
Signaling
We then studied the postsynaptic striatal compartment by
analyzing dendritic trafficking and signaling responses to cortical
stimulation. We investigated the dynamics of dendritic vesicles
containing tropomyosin-related kinase receptor B (TrkB), the
receptor for BDNF. TrkB is endogenously expressed in striatal
neurons, and defects in its trafficking and signaling capacity
have been described in HD (Brito et al., 2014; Liot et al., 2013;
Plotkin et al., 2014). Striatal neurons were infected with a lenti-
virus expressing a fully functional mCherry-tagged TrkB receptor
(TrkB-mCh) and electroporated with a plasmid expressing
MAP2-GFP, for the recording of TrkB vesicular dynamics specif-
ically in dendrites (Figure 4A; Movie S4). Kymograph analyses
were performed at DIV 14, when the network was mature (Fig-
ures 4B and S4A). In HD corticostriatal networks, the number
of TrkB vesicles were reduced in both anterograde and retro-
grade directions, as previously reported in young immature cul-
tures (Liot et al., 2013) (Figure 4C). These changes led to a large
decrease in the global linear flow rate of vesicle trafficking in
striatal dendrites.
We then investigated the consequences of altered synaptic
transmission for postsynaptic signaling, using ERK phosphoryla-
tion as a readout of the striatal response to cortical stimulation
(Figures S4B and S4C). We found a significant decrease in the
number of phospho-ERK-immunopositive striatal neurons in
response to cortical stimulation with glycine/strychnine treat-
ments in the context of HD (Figures 4D and 4E). We confirmed
the defect in the phospho-ERK-signaling pathway using western
blotting analyses of striatal cell bodies extracted from the micro-
fluidic platform (Figures 4F and 4G). Interestingly, we found that
the decrease in postsynaptic phospho-ERK signaling preferen-
tially affected enkephalin-positive striatal neurons (Figures
S4D–S4F), which correspond to output-projecting neurons of
the striatum that are particularly affected in HD (Saudou and
Humbert, 2016). Thus, in addition to the presynaptic and synaptic
defects, there were also profound changes to postsynaptic intra-
cellular dynamics and signaling in the HD corticostriatal network.
Corticostriatal Connectivity Is Defective and
Hypersynchronized in HD
We next studied the global consequences of these alterations
on the global functioning of the network. To do so, we infected
striatal neurons with an adeno-associated virus expressing
GCaMP6f, and we analyzed spontaneous responses to cortical
inputs (Movie S5). In WT neurons, we recorded sustained
neuronal activity with numerous episodes of bursting activity
and single asynchronous events within the network at DIV
10–14 (Figures 5A, S5A, and S5B). By contrast, HD neurons
Figure 3. Impaired Synaptic Structure and
Function in the HD Network
(A–D) Decreased synaptic connections in HD.
(A) Airyscan confocal images show SYN/PSD95
colocalization in the synaptic chamber of WT and
HD corticostriatal network at DIV 14. Insets show
103 magnification of representative branches.
Scale bars, 20 mm (insets, 2 mm).
(B) Quantification of the number of adjacent SYN/
PSD95 spots per branches shows decreased
synaptic connections in HD neurons (***p < 0.001;
n = 27).
(C) Synaptophysin spots can be distributed based
on their size and grouped into 3 categories: small
(<0.3 mm2), large (0.3–2 mm2), and clustered
(>2 mm2), as shown in the inset. Scale bar, 2 mm.
(D) Quantification of synaptophysin spot size
shows a decreased number of small, restricted
synaptic sites and increased number of large and
clustered sites in the HD network (**p < 0.01 and
****p < 0.0001; n = 9).
(E–G) Impaired glutamate transmission at cortico-
striatal synapses in HD.
(E) Images show iGluSnFR deflection in fluores-
cence in the synaptic chamber of WT and HD
network at DIV 14 after chemical stimulation of
cortical neurons. Insets show 43 magnification
of striatal postsynaptic sites responding to pre-
synaptic release of glutamate. Scale bars, 20 ı̀m
(insets, 5 ı̀m).
(F) Quantification of the number of iGluSnFR
spots per millimeter2 shows decreased glutamate
transmission sites between cortical and striatal
neurons in HD (****p < 0.0001; n = 25).
(G) Quantification of iGluSnFR spot size shows
fewer small, restricted transmission sites and an
increased number of large, diffuse sites in the
HD network (*p < 0.05; n = 26). Error bar in-
dicates SEM.
See also Figure S3.remained silent, as shown by themuch smaller number of events
than for WT striatal neurons (Figure 5B). However, although HD
neurons were only half as active as WT neurons, they displayed
highly synchronized bursting episodes separated by long
phases of inactivity (Figure 5A; Movie S5). Furthermore, the
amplitude of bursting episodes was three times higher than
that in WT neurons (Figure 5C).
We then compared the occurrence of synchronous events be-
tween WT and HD neurons (Figures 5D and S5C). We found that
only one-third of events were synchronized inWT neurons at this
stage. By contrast, in HD neurons, this proportion increased to
more than two-thirds, suggesting a dramatic functional reorgani-
zation of the corticostriatal network. This change in synchrony
indicates that, while the system remains globally silent, sparse
episodes of intense bursting transmission may occur at randomCelland are propagated uniformly throughout
the striatum. These findings may reflect
the smaller number of functional synap-
ses, together with the larger presynaptic
clusters and glutamate release sites(Figure 3), potentially leading to the rare, but uncontrolled,
massive release of neurotransmitters. We therefore conclude
that, in HD, the corticostriatal network reorganizes into an abnor-
mally overactive system that may propagate irrelevant cortical
information, ultimately compromising the survival of striatal
neurons.
The Genetic Status of the Presynaptic Compartment
Determines Network Integrity
Several studies have highlighted the importance of autonomous
defects within the striatum and of the contribution of both striatal
and corticostriatal projecting neurons to circuit dysfunction and
degeneration (Buren et al., 2016; Estrada-Sánchez et al., 2015;
Wang et al., 2014; Plotkin et al., 2014). The fluidic isolation
of the pre- and postsynaptic compartments, with an isolatedReports 22, 110–122, January 2, 2018 115
Figure 4. Alterations in Postsynaptic Dynamics and
Signaling in HD Striatal Neurons
(A–C) Impaired dendritic trafficking (TrkB-mCh) in HD.
(A) Images taken from live-cell recordings show TrkB-mCh
vesicles traveling in MAP2-positive dendrites of striatal neu-
rons (see Movie S4). Scale bar, 10 mm.
(B) Representative kymographs show TrkB-mCh dendritic
trafficking obtained in WT and HD neurons at DIV 14.
(C) Kinetics analysis of dendritic transport shows decreased
numbers of anterograde and retrograde vesicles, leading to
decreased global linear flow rate in HD neurons (*p < 0.05 and
**p < 0.01; n = 31).
(D–G) Impaired phospho-ERK signaling in HD postsynaptic
striatal neurons.
(D) Images show pERK immunofluorescence in the striatal
chamber of WT and HD networks at DIV 14 after glycine/
strychnine stimulation of cortical neurons. DAPI co-staining
was used to evaluate the total number of neurons for quan-
tification. Scale bars, 100 mm.
(E) Quantification of pERK-positive cells after cortical stimu-
lation shows a decreased response in HD striatal neurons
(****p < 0.0001; n = 20).
(F) Western blot of phospho- and total ERK1/2 from striatal
neurons of WT and HD networks at DIV 14 after glycine/
strychnine stimulation of cortical neurons is shown.
(G) Quantification of pERK/ERK bands after cortical stimula-
tion shows a dramatic decrease in pERK signaling in HD
striatal neurons (***p < 0.001; n = 6). Error bar indicates SEM.
See also Figure S4 and Movie S4.
116 Cell Reports 22, 110–122, January 2, 2018
Figure 5. Dysfunctional Reorganization of
Corticostriatal Connectivity and Synchrony
in the HD Network
(A) Representative GCaMP6f fluorescent traces
(one trace per neuron) obtained from WT and HD
striatal neurons show the global reorganization of
network activity in HD (see Movie S5).
(B–D) Quantifications of GCaMP6f dynamics show
alterations at different levels of neuronal activity
and synchrony in the HD network. (B) Decreased
number of events per cells (****p < 0.0001; n = 757),
(C) increased amplitude of response per event
(****p < 0.0001), and (D) global increase in the
proportion of highly synchronized events in
HD striatal neurons compared to WT neurons
(WT, 38.8%; HD, 67.1%) are shown. Error bar in-
dicates SEM.
See also Figure S5 and Movie S5.synaptic space, provided the opportunity to manipulate the ge-
netic status of the cortical and striatal neurons independently
within the reconstituted network. We therefore placed either
WT or mutant HdhCAG140/+ neurons in both cortical and striatal
compartments (WT-WT and HD-HD), or we used WT cortical
neurons with mutant HdhCAG140/+ striatal neurons (WT-HD) or
mutant HdhCAG140/+ cortical neurons with WT striatal neurons
(HD-WT) (Figure 6A). We then investigated the contribution of
each compartment to the observed network defects in our mi-
crofluidic device.
We investigated glutamate transmission, and we found that
an HD-WT corticostriatal network was sufficient to recapitulate
the deficits in transmission observed in a full HD-HD network
(Figure 6B). By contrast, the WT-HD network closely resembled
the full WT-WT network, suggesting that synaptic alterations
are independent of the postsynaptic compartment in HD. We
then measured ERK signaling within striatal neurons, as this
striatal response is typically altered in HD (Brito et al., 2014;
Liot et al., 2013; Plotkin et al., 2014). Surprisingly, HD striatal
neurons displayed no phospho-ERK signal defect when the
cortical neurons were WT (WT-HD network) (Figure 6C). By
contrast, WT striatal neurons yielded defects similar to those
of mutant neurons when the cortical neurons were HD
(HD-WT network). These observations were confirmed using
phospho-ERK western blotting analyses performed selectively
from neuronal cell bodies of the striatal chamber (Figure 6D).
Thus, presynaptic cortical neurons have a critical impact on
the maintenance of striatal neurons, suggesting that the basalCellfunctioning and survival of striatal neu-
rons depends on corticostriatal projec-
tions rather than on cell-autonomous
mechanisms. We further analyzed global
communication and synchrony between
cortical and striatal neurons in all four
genetic conditions, through the viral
expression of GCaMP6f in striatal neu-
rons. Again, we found that neuronal ac-
tivity in the HD-WT network resembled
that in the full HD-HD network (smallernumber of events, a larger amplitude, and highly synchronized
bursting events) (Figures 6E–6G). By contrast, WT presynaptic
neurons were able to maintain correct connectivity and syn-
chrony even when the striatal neurons were of the HD genotype
in the WT-HD network.
To generalize our observations that presynaptic alterations are
necessary and sufficient to induce synapse and network dys-
functions in HD, we repeated this set of experiments using
another widely used HD mouse model. To do so, iGluSnFR,
phospho-ERK, and GCamP6f analyses were performed using
the heterozygous knockin HdhQ111/+ mice that express human
HTT exon 1 sequence with 109 repeats of CAG (Wheeler et al.,
1999). Using this model, we confirmed that the HD-WT configu-
ration recapitulated dysfunctions observed in the full HD-HD
network at the level of synaptic transmission (decreased
iGluSnFR density), postsynaptic signaling (decreased phos-
pho-ERK-positive cells and phospho-ERK western blot signal
after cortical stimulation), and network connectivity (decreased
number of GCaMP6f events, increased amplitude, and
increased number of highly synchronized bursting events)
(Figure S6). As previously observed with HdhCAG140/+ cultures,
HdhQ111/+ striatal neurons showed no synaptic, postsynaptic,
or synchrony dysfunctions when cortical neurons were of
the WT genotype (WT-HD network) and resembled the full
WT-WT configuration. We therefore conclude that the genetic
status of the cortical neurons determines the function and
dysfunction of the corticostriatal network in neurons from two
mouse models of HD.Reports 22, 110–122, January 2, 2018 117
Figure 6. Selective Contribution of Pre- and
Postsynaptic Compartments to Local and
Global Dysfunctions in HD Neurons
(A) Strategy for manipulating the genetic status
of presynaptic and postsynaptic neurons. Four
combinations were tested: full WT (WT-WT), full
HD (HD-HD), cortical WT + striatal HD (WT-HD),
and cortical HD + striatal WT (HD-WT).
(B) Quantification of the number of iGluSnFR spots
shows altered glutamate transmission (F3,120 = 8.7,
p < 0.0001; n = 30) in the HD-HD network, which
is fully recapitulated in the HD-WT condition
(*p < 0.05 and **p < 0.01; HD-WT compared
to HD-HD, not significant [n.s.]). The WT-HD
network is not significantly different from the WT-
WT condition.
(C and D) Alteration in striatal pERK signaling of the
HD-HD network is recapitulated in the HD-WT
configuration.
(C) Quantification of pERK-positive cells after
cortical stimulation shows a decrease in striatal
signaling (F3,94 = 22.2, p < 0.0001; n = 25) in HD-HD
and HD-WT networks (****p < 0.0001; HD-WT
compared to HD-HD, n.s.), but not in WT-HD
neurons.
(D) A dramatic decrease in pERK western blot
signal (F3,20 = 3.8, p < 0.05; n = 6) is found in HD-
HD and in HD-WT networks (*p < 0.05; HD-WT
compared to HD-HD, n.s.), but not in WT-HD
neurons.
(E–G) Quantifications GCaMP6f dynamics show
alterations in neuronal activity and synchrony in
HD-HD that are fully recapitulated in the HD-WT
network.
(E) A similar decrease in the number of events per
cells (F3,2027 = 28.0, p < 0.0001; n = 507) in HD-HD
and HD-WT (*p < 0.05, ***p < 0.001, and
****p < 0.0001; HD-WT compared to HD-HD, n.s.)
but a small increase in WT-HD neurons (*p < 0.05)
are shown.
(F) A similar increase in amplitude of response
(F3,2027 = 57.2, p < 0.0001) in HD-HD and HD-WT
(****p < 0.0001; HD-WT compared to HD-HD, n.s.),
but not in WT-HD neurons, is shown.
(G) A high proportion of highly synchronized events in HD-HD and HD-WT neurons (53.8% and 66.2%, respectively), but not in WT-WT and WT-HD neurons
(42.5% and 36.5%, respectively), is shown. Error bar indicates SEM.
See also Figure S6.Corticostriatal Activity Is Necessary and Sufficient to
Induce Striatal Dysfunctions In Vitro and In Vivo in HD
Because of the contribution of the presynaptic compartment to
HD dysfunctions, we directly assessed whether neuronal activity
of cortical neurons is sufficient to induce alterations in the corti-
costriatal circuitry, both in vitro and in vivo. We took advantage of
the fluidic isolation of the microchamber to selectively manipu-
late neuronal activity of cortical neurons with tetrodotoxin (TTX,
a sodium channel blocker) while assessing network activity
and synchrony (Figure 7A). As we previously observed, HD-HD
networks treated with saline solution showed long episodes of
silent activity interrupted by highly synchronized and massive
bursting events, in clear contrast with the sparse and moderate
activity in the WT-WT network (Figure 7B). Interestingly alter-
ations in HD network activity and synchrony were dramatically
decreased after TTX treatment of cortical neurons, as shown118 Cell Reports 22, 110–122, January 2, 2018by the increased number of events, decreased amplitude, and
lower proportion of synchronized events (Figures 7C–7E). These
results suggest that abnormal cortical activity is necessary to
induce aberrant corticostriatal connectivity in HD.
We next investigated whether cortical activity could drive
in vivo alterations in striatal signaling responses using acute
brain slices from WT and HD mice. Cortical projecting neurons
from the layer V were electrically stimulated in acute horizontal
brain slices from WT and HdhCAG140/+ mice preserving cortico-
striatal projections (Fino et al., 2005). Phospho-ERK signaling
was then quantified using immunostaining in the corresponding
projecting area of the striatum (Figure 7F). High-frequency
stimulations of cortical neurons efficiently activated phospho-
ERK signaling in the striatum, as shown by the increased num-
ber of phospho-ERK-positive neurons in the corresponding
target area of the striatum (Figure 7G). In HD mice, the number
Figure 7. Striatal Consequences of Cortical Activity
Manipulation In Vitro and In Vivo in HD
(A) Schematic showing the strategy for the selective inhibition of
cortical activity using TTX. (B) Representative GCaMP6f traces
obtained from WT and HD striatal neurons with or without cortical
treatment with TTX.
(C–E) Quantifications of GCaMP6f dynamics show normal
neuronal activity and synchrony in the HD network after cortical
treatment with TTX. (C) Alterations in the number of events per
cells (***p < 0.0001; n = 480), (D) amplitude of response per event
(***p < 0.0001), and (E) the proportion of highly synchronized events
in HD striatal neurons (WT, 29.1%; HD, 67.8%; HD + TTX, 35.7%)
are rescued by cortical TTX.
(F–H) Cortical stimulations in acute brain slices induce impaired
corticostriatal signaling in HD striatum.
(F) Schematic depicts the localization of electrical stimulations of
layer V projecting neurons (ON) as well as the corresponding region
of interest for pERK quantifications. In basal conditions, the elec-
trode was placed but no stimulation was applied (OFF).
(G) Representative bright-field images show phospho-ERK-posi-
tive neurons in the striatum of WT and HD mice, in the basal con-
dition and after cortical stimulation.
(H) Quantifications show an increased number of pERK-positive
neurons after cortical stimulation inWT, but not HD, striatum in vivo
(F3,80 = 8.1, p < 0.0001; n = 21; ***p < 0.001 and **p < 0.01; n.s., not
significant). Error bar indicates SEM.
Cell Reports 22, 110–122, January 2, 2018 119
of phospho-ERK-positive striatal neurons was significantly
decreased after cortical stimulations (Figure 7H), suggesting
decreased corticostriatal connectivity and activity. We therefore
conclude that cortical activity in HD is involved in corticostriatal
network dysfunctions in vitro and in vivo. These results also sug-
gest that cortical areas represent an important target to consider
for therapeutic strategies.
DISCUSSION
Studying intracellular and synaptic dynamics in vivo is a chal-
lenge, although it is critical to better understand how distinct
neuronal populations interact. The current challenge in studying
cellular mechanisms within neurons is that in vitro cultures
weakly recapitulate the physiology of neuron-to-neuron commu-
nication, especially within neurons of different identities. This is
particularly important in the case of neurological disorders in
which specific circuitries are damaged. Here we present
an in vitro system compatible with high-resolution videomicro-
scopy, allowing the reconstruction and manipulation of func-
tional and oriented neuronal networks that possess the
characteristics of mature circuitry found in vivo (Figure S7). Using
this original approach, we reconstructed an HD network on-
a-chip, and we identified specific intracellular events that are
selectively altered in disease.
Changes in Intracellular and Synaptic Dynamics in HD
Depend on the Presynaptic Compartment
The HD corticostriatal circuit displayed marked changes to the
dynamics of axonal vesicles. Defects in fast axonal transport
appeared very early in the development of the network, and
the alterations persisted even in the mature network. This sug-
gests that the axonal transport defects in HD are probably an
early pathogenic mechanism established during the develop-
ment of neuronal circuits in the brain. Contrasting defects in
axonal trafficking were observed for secretory vesicles andmito-
chondria, with vesicular dynamics progressively decreasing
whereas mitochondrial motility increased. These changes in
mitochondrial transport occurred at late stages of culture,
when the circuit was mature, and they were correlated with an
increase in the number of smaller mitochondria. These findings
suggest that small, highly motile mitochondria are trafficked in
the axons of HD neurons, contrary to the findings of previous
studies reporting a decrease in mitochondrial trafficking (Chang
et al., 2006; Orr et al., 2008; Trushina et al., 2004). However,
these differences may result from the experimental conditions
used. Indeed, short fragments of mutant huntingtin generating
high levels of aggregates in axons and dendrites were used,
and the authors linked the observed impairment of trafficking
to the presence of aggregates. Nevertheless, abnormalities of
both vesicular and mitochondrial motility may also predispose
neurons to synapse dysfunction, as observed in neurons with
syntaphilin mutations, in which mitochondrial motility increased
due to anchoring impairment (Kang et al., 2008). Consistently,
we observed a decrease in the density of corticostriatal syn-
apses, with reduced BDNF-TrkB dynamics and glutamatergic
transmission. These alterations may underlie the decrease in
striatal signaling and basal neuronal activity, since both the120 Cell Reports 22, 110–122, January 2, 2018BDNF-TrkB-signaling pathway and glutamatergic transmission
have been shown to regulate downstream ERK signaling in stria-
tal neurons (Baydyuk and Xu, 2014). Importantly, we found these
alterations to occur specifically in the enkephalin-positive me-
dium spiny projection neurons and prior to any cell death events,
suggesting that our model recapitulates early events in disease.
Surprisingly, despite remaining silent most of the time, HD
striatal neurons elicited sudden, exaggerated, and highly syn-
chronized responses to spontaneous network activity (Figure 5).
This hypersynchrony probably resulted from a dysregulation in
neurotransmitter release at the presynaptic site that was suffi-
cient to impair the full network. Consistent with this hypothesis,
a previous study in a Drosophila model of HD reported an in-
crease in Ca2+-dependent neurotransmitter release, and it
showed that reducing synaptic transmission via a partial
loss of function of voltage-gated Ca2+ channels abolished
both the electrophysiological and neurodegenerative pheno-
types (Romero et al., 2008). These observations can be related
to our findings showing altered synaptic connections and
impaired excitatory glutamatergic transmission in HD (Figure 3).
In fact, in both cases aberrant and large clusters were observed,
suggesting dysfunctional and excessive release of excitatory
neurotransmitter at presynaptic sites. Together, this cortico-
striatal hyperactivity may contribute to corticostriatal dysfunc-
tion and ultimately lead to neurodegeneration (Lewerenz and
Maher, 2015).
This device allows one to manipulate the genetic status of pre-
or postsynaptic neurons independently. Using this capacity, we
showed that the nature of presynaptic neurons dominates the
functionality of the whole network. Indeed, WT cortical neurons
are sufficient to rescue network functionality and survival
signaling in the HD striatum. Conversely, HD cortical neurons
are sufficient to impair striatal signaling as well as the global
functioning of the corticostriatal network. These findings are in
agreement with a previous study (Zhao et al., 2016), and they
have important implications for therapeutic strategies, as they
support the notion that the cortex is a key structure in gene
therapy approaches aiming to restore striatal function.
A Microfluidic Platform for Studying Multiple Brain
Disorders
Given its versatility, the microfluidic platform can be used for
almost any type of neuronal circuits or brain disorders. Here
we challenged the system using a model of a neurodegenerative
disorder by reconstructing a physiologically relevant cortico-
striatal network, such as the one that is affected in HD. We
cultured corticostriatal projecting neurons (CTIP2/TBR1 posi-
tive) in the cortical chamber and output medium spiny neurons
(enkephalin positive) in the striatal chamber. Using this system,
we showed that the loss of correct corticostriatal connectivity
can lead to unexpected consequences for striatal function,
such as exaggerated and hypersynchronized responses to
cortical signals. In addition, this network on-a-chip highlights
the crucial role played by the presynaptic compartment in the
sequence of events leading to striatum dysfunction and, ulti-
mately, to degeneration. These results constitute a proof of
concept for the utility of newly developed microfluidic systems
for improving our understanding of the intracellular mechanisms
involved in the pathogenesis of brain disorders. Alternatively,
other brain disorders involving hyperconnected networks, such
as autism spectrum disorder (ASD) and/or attention deficit hy-
peractivity disorder (ADHD), could also be modeled. Microfluidic
systems using cortical and striatal neurons from mouse models,
such as SHANK3-knockout mice (Peça et al., 2011), could be
used to determine the sequence of cellular dysfunctions leading
to the defects in corticostriatal circuits typical of the disease. The
combination of fluidic isolation and oriented neuronal connec-
tions would make it possible to trigger a primary pathogenic
event in one identified compartment and to study the propaga-
tion of secondary dysfunctions in a controlled spatial and tempo-
ral environment.
In conclusion, we present a corticostriatal network on-a-chip
using a microfluidic device suitable for high spatial and temporal
resolution imaging. By applying this device to HD, we discovered
unexpected cellular and network dysfunctions, highlighting the
crucial role played by the cortical compartment in the genesis
of striatal symptoms. This on-a-chip approach may prove to be
useful for deciphering pathophysiological mechanisms and for
validating drugs of therapeutic interest.
EXPERIMENTAL PROCEDURES
Further details and an outline of resources used in this work can be found in the
Supplemental Experimental Procedures.
Mice
HdhCAG140/+ knockin mice were generated on a C57BL/6J background, and
they express human HTT exon 1 sequence with 140 repeats of CAG, as
described previously (Menalled et al., 2002). HdhQ111/+ knockin mice are
generated on a CD1 background, and they express human HTT exon 1
sequence with 109 repeats of CAG, as described previously (Wheeler et al.,
1999). Animals were maintained with access to food and water ad libitum
and kept at a constant temperature (19C –22C) and humidity (40%–50%)
on a 12:12-hr light/dark cycle. All experimental procedures were performed
in an authorized establishment (Grenoble Institut des Neurosciences, INSERM
U1216, license B3851610008) in strict accordance with the recommendations
of the European Community (86/609/EEC) and the French National Committee
(2010/63) for care and use of laboratory animals, under the supervision of
authorized investigators (permission 91-448 to S. Humbert). Regarding
controlled crosses, WT C57BL/6J or HdhCAG140/CAG140 male mice and WT
CD1 or HdhQ111/Q111 male mice were mated, respectively, for one night with
WT C57BL/6J or CD1 female mice.
Statistical Analyses
Statistical significance was determined using Prism5 (GraphPad). Synaptic
transmission (iGluSnFR), postsynaptic signaling (pERK immunostaining, west-
ern blots, and immunochemistry), and network connectivity (GCaMP6f) were
analyzed using one-way ANOVA followed by a Tukey post hoc test when
more than two conditions were compared within a group (genotypes). Traf-
ficking kinetics (BDNF-mCh and Mito-DsRed) were analyzed using two-way
ANOVA followed by a Tukey post hoc test when comparing more than 2 vari-
ables (DIV and genotypes). Synaptic formation (SYN/PSD95 and VGLUT1/
PSD95), synaptic transmission (iGluSnFR), trafficking kinetics (TrkB-mCh),
size classification (Mito-DsRed, iGluSnFR, and SYN), postsynaptic signaling
(pERK immunostaining and western blot), mitochondrial function (TMRM),
and network connectivity (GCaMP6f) were analyzed using unpaired two-tailed
Student’s t tests when only two conditions were compared within a group
(WT versus HD). The distributions of motile vesicles (BDNF-mCh) and syn-
chrony (GCaMP6f) were analyzed using a Pearson’s chi-square test. Results
are expressed as mean ± SEM. The criterion for statistical significance was
set at p < 0.05.SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
seven figures, and five movies and can be found with this article online at
https://doi.org/10.1016/j.celrep.2017.12.013.
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